Abstract

Systemic sclerosis is a chronic inflammatory disease modulated by pro-inflammatory cytokines, hence associated with cardiovascular disease. Standard modifiable cardiovascular risk factors (SMuRFs; hypercholesterolaemia, hypertension, diabetes and smoking) and non-traditional risk factors (NTRFs; chronic renal impairment, obstructive sleep apnoea and obesity) are established drivers of cardiovascular disease; however, their impact remains undefined in populations with systemic sclerosis. We sought to assess the prognostic impact of SMuRFs and NTRFs in patients with systemic sclerosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call